XML 53 R40.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Disaggregated Expenses
The following tables present disaggregated expenses that are regularly provided to the CODM:
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Personnel compensation and related costs22,447 31,209 46,527 59,217 
Licensing fees— — 19,997 — 
CROs/CMOs/Investigators expenses19,935 24,305 29,765 44,209 
Other costs8,232 6,111 15,054 12,844 
Total research and development expenses50,614 61,625 111,343 116,270 
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Clinical programs16,967 21,348 45,059 40,136 
Pre-Clinical programs5,069 3,139 8,383 5,188 
Unallocated research and development expenses28,578 37,138 57,901 70,946 
Total research and development expenses50,614 61,625 111,343 116,270 

Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Personnel compensation and related costs42,679 48,279 83,322 94,173 
Other costs28,359 31,431 51,138 54,731 
Total selling, general, and administrative expenses71,038 79,710 134,460 148,904 
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Selling and marketing expenses46,764 53,275 88,703 96,869 
General and administrative expenses24,274 26,435 45,757 52,035 
Total selling, general, and administrative expenses71,038 79,710 134,460 148,904